Core Scientific (CORZ) Payables (2021 - 2026)

Core Scientific has disclosed Payables across 6 years of filings, most recently posting $218.9 million for Q1 2026.

• Payables for Q1 2026 came in at $218.9 million, up 870.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $218.9 million (up 870.89% YoY), and the FY2025 annual result was $126.1 million, up 254.68% from the prior year.
• Payables came in at $218.9 million for Q1 2026 at Core Scientific, up from $126.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.0 billion in Q3 2022 to a low of $22.5 million in Q1 2025.
• The 5-year median for Payables is $125.8 million (2022), against an average of $178.1 million.
• Across the five-year window, Payables soared 145872.92% in 2022 and slumped 87.26% in 2024, its largest moves.
• Core Scientific's Payables stood at $89.9 million in 2022, then surged by 210.52% to $279.1 million in 2023, then plunged by 87.26% to $35.6 million in 2024, then jumped by 254.68% to $126.1 million in 2025, then soared by 73.55% to $218.9 million in 2026.
• The last three Payables figures came in at $218.9 million (Q1 2026), $126.1 million (Q4 2025), and $212.2 million (Q3 2025), per Business Quant data.